Author

Michael Currier

Observed name: Currier, Michael

Institutions: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases

Observed institutions: Centers for Disease Control and Prevention, Battelle, Emory University, National Center for Immunization and Respiratory Diseases, Children's Healthcare of Atlanta, Oak Ridge Institute for Science and Education, The University of Texas Medical Branch at Galveston

OpenAlex ID: A5108493540

Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines

2022 · Li Wang, Markus H. Kainulainen, et al. · Nature Communications · 50

An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virus

2024 · Masato Hatta, Yasuko Hatta, et al. · Science Translational Medicine · 41

Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses

2021 · Li Wang, Xiaoyu Fan, et al. · Emerging infectious diseases · 36

Fluorescent and Bioluminescent Reporter Myxoviruses

2016 · Christina Rostad, Michael Currier, et al. · Viruses · 10

Influenza mRNA vaccine reduces pathogenicity and transmission of A(H5N1) virus in a ferret model

2025 · Masato Hatta, Nicole Brock, et al. · npj Vaccines · 8

Impact of naturally occurring hemagglutinin substitutions on antigenicity and fitness of influenza A(H5N1) virus

2025 · Li Wang, Masato Hatta, et al. · npj Viruses · 5

Bivalent mRNA vaccine improves antibody-mediated neutralization of many SARS-CoV-2 Omicron lineage variants

2023 · Nannan Jiang, Li Wang, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5

Development and Characterization of Candidate Vaccine Viruses Against High Pathogenicity Avian Influenza A(H5) Viruses for Rapid Pandemic Response

2026 · Li Wang, Jieru Wang, et al. · The Journal of Infectious Diseases · 3

Development of pre-pandemic influenza candidate vaccine viruses for use in vaccine manufacturing

2026 · Li Wang, Cindy Adolphus, et al. · npj Vaccines · 2

Structural basis of the American mink ACE2 binding by Y453F trimeric spike glycoproteins of SARS‐CoV‐2

2023 · Hyunjun Ahn, Brenda M. Calderon, et al. · Journal of Medical Virology · 2

ACE2 Receptor Usage across Animal Species by SARS-CoV-2 Variants

2025 · Masato Hatta, Gloria P. Larson, et al. · Emerging infectious diseases · 1

A DirectView focus reduction assay for high-throughput quantification of neutralizing antibodies against influenza A and B viruses

2026 · Chenchen Feng, Thomas Rowe, et al. · Cell Reports Methods

Generating Neutralizing Antibody responses using Recombinant Infectious Rhinovirus

2018 · Sujin Lee, Roderick Tang, et al. · The Journal of Immunology

B cell and peptide based immunotherapy vaccine for Respiratory Syncytial Virus (RSV) infection (52.16)

2010 · Sujin Lee, Michael Currier, et al. · The Journal of Immunology

Works count: 15

Citation count: 163

H-index: 5

I10-index: 4